Millionaire Maker or Market Hype? The Honest Truth About NuScale Power.

NuScale Power’s market cap has fallen ~75% from a mid-October 2025 peak, now around $3.6B, with shares priced below $10. The article frames upside as requiring roughly a 100x stock move to reach ~$360B market value (or ~$182B for a $50K-to-$1M outcome), contingent on widespread global SMR adoption and no major setbacks. However, it highlights weak fundamentals—minimal revenue and the collapse of its first major U.S. project in late 2023 after cost estimates rose—keeping the outlook skewed cautious.

Analysis

This is less about nuclear demand and more about the market re-pricing pre-commercial optionality. When a name depends on decade-out adoption but lacks a binding customer and a clean financing path, the discount rate can move faster than the story; that tends to compress multiples across the entire “AI power” basket. The relative winners are cash-generative nuclear proxies with nearer-term earnings visibility, especially CEG, CCJ, and BWXT, because they can monetize power scarcity without taking FOAK execution risk.

Over the next 1-3 months, SMR should trade as a sentiment and positioning vehicle, not a fundamentals compounder. Any bounce driven by retail attention is likely to be sold unless management can show a financed, contracted project with credible capex discipline; absent that, the stock remains vulnerable to dilution-driven downside even if the equity story gets louder. The key falsifiers are a signed utility commitment, third-party validation of project economics, or government-backed support that materially lowers funding risk.

For 6-18 months, the issue is whether SMR becomes a real industrial business or stays a call option on policy and AI power demand. The contrarian risk is that the market may be underestimating the value of one credible deployment in a constrained grid environment, but that option is not yet worth paying a growth multiple for. Until backlog converts to contracted revenue, the better trade is to own the proven beneficiaries of nuclear scarcity and short the expensive execution risk.

Key Decisions for Investors

• Short SMR on strength or sell 1-3 month rallies; target a move back toward post-hype valuation bands. Thesis breaks if SMR announces a binding customer contract plus project financing with credible capex/return metrics.
• Pair trade: long CEG or CCJ, short SMR for 3-6 months to isolate execution-risk spread. This works if investors rotate from speculative nuclear names into cash-generating power and fuel-cycle exposure.
• If options liquidity is usable, buy a 3-6 month SMR put spread rather than outright puts to define risk. Best entry is after any retail-driven spike; invalidation is a de-risking announcement or strategic investment at favorable terms.
• Use URA/NLR as cleaner sector exposure and avoid SMR until there is visible backlog conversion. The sector may work even if SMR does not, which makes single-name exposure the inferior risk/reward.